@article{11b01e988c694f6c96f505d9d756533d,
title = "Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health",
keywords = "adrenergic beta-antagonists, blood pressure, capillary hemangioma, child, growth and development, infant, long-term adverse effects, vascular malformations, vascular tissue neoplasms",
author = "Hermans, \{Mireille M\} and Pasmans, \{Suzanne G M A\} and \{de Laat\}, \{Peter C J\} and Slieker, \{Martijn G\} and Mendels, \{Elodie J\} and \{de Graaf\}, Marlies and Langeveld, \{Hester R\} and Renske Schappin and Rietman, \{Andr{\'e} B\} and Breugem, \{Corstiaan C\} and Breur, \{Johannes M P J\} and \{de Wildt\}, \{Saskia N\} and Raphael, \{Martine F\}",
note = "Funding Information: Funding sources: This investigator-initiated study was carried out with an unrestricted grant provided by Pierre Fabre Dermatologie. ",
year = "2023",
month = jun,
doi = "10.1016/j.jdin.2023.02.001",
language = "English",
volume = "11",
pages = "137--139",
journal = "JAAD international",
issn = "2666-3287",
publisher = "Elsevier",
}